Table 4.
Antimicrobial Activity of Ceftolozane/Tazobactam, Ceftazidime, Meropenem, and Piperacillin/Tazobactam Against Isolates of P. aeruginosa stratified by Country for Countries with 10 or More Isolates
| Country (No. Tested) | % Susceptible (No. Susceptible)a | |||
|---|---|---|---|---|
| Ceftolozane/Tazobactam | Ceftazidime | Meropenem | Piperacillin/Tazobactam | |
| Japan (19) | 89.5 (17) | 73.7 (14) | 73.7 (14) | 78.9 (15) |
| Korea (81) | 95.1 (77) | 72.8 (59) | 70.4 (57) | 67.9 (55) |
| Malaysia (72) | 90.3 (65) | 87.5 (63) | 77.8 (56) | 91.7 (66) |
| Philippines (68) | 97.1 (66) | 86.8 (59) | 89.7 (61) | 82.4 (56) |
| Singapore (19) | 89.5 (17) | 84.2 (16) | 84.2 (16) | 73.7 (14) |
| Taiwan (37) | 97.3 (36) | 89.2 (33) | 70.3 (26) | 78.4 (29) |
| Thailand (73) | 80.8 (59) | 72.6 (53) | 64.4 (47) | 78.1 (57) |
Notes: aSusceptible based on criteria published by CLSI.29 Vietnam not shown as it had 7 P. aeruginosa isolates.